Ms. Anna Ivanova: Research Coordinator, Nicotine Dependence Service, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.Dr. Dolly Baliunas: Collaborator Scientist, Nicotine Dependence Service, Centre for Addiction and Mental Health, Toronto, Ontario, Canada, and Assistant Professor, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.Ms. Sheleza Ahad: Project Coordinator, Nicotine Dependence Service, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.Ms. Elise Tanzini: Research Coordinator, Nicotine Dependence Service, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Ms. Rosa Dragonetti: Project Director, Addictions Education and Research, Nicotine Dependence Service, Centre for Addiction and Mental Health, Toronto, Ontario, Canada, and Assistant Professor, Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.Ms. Myra Fahim: Clinic Manager, Nicotine Dependence Service, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.Dr. Peter Selby: Senior Medical Consultant, Centre for Addiction and Mental Health, Toronto, Ontario, Canada, Clinician Scientist, Addictions, Research Program, Clinical Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada, Clinician Scientist, Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada, and Professor, Departments of Family and Community Medicine, Psychiatry, and Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Correspondence: Peter Selby, MBBS, CCFP(AM), FCFP, MHSc, DipABAM, DFASAM, Nicotine Dependence Service, Centre for Addiction and Mental Health, 1025 Queen Street West, Toronto, ON M6J 1H4, Canada; e-mail: [email protected].
Funding for the Smoking Treatment for Ontario Patients (STOP) and Training Enhancement in Applied Counseling and Health (TEACH) programs provided by the Ministry of Health and Long-Term Care (MOHLTC), as part of the Smoke Free Ontario Strategy. The findings in, and conclusions of, this study are those of the authors and do not necessarily represent the official position of the MOHLTC. This study did not receive any external funding.
Disclosures: D.B. and P.S. report grants from Canadian Institutes of Health Research, Pfizer Inc. through the Global Research Awards in Nicotine Dependence (GRAND) program. P.S. additionally reports grants, salary, and/or research support from Centre for Addiction and Mental Health, Health Canada, Ontario Ministry of Health and Long-Term Care, Canadian Centre on Substance Use and Addiction, Public Health Agency of Canada, Medical Psychiatry Alliance, Canadian Cancer Society Research Institute, Cancer Care Ontario, and the Ontario Institute for Cancer Research, as well as from the following commercial entities: Pfizer Inc. and Patient-Centered Outcomes Research Institute. P.S. has also received honoraria for speaking engagements from Pfizer Canada Inc. Through an open tender process, Johnson & Johnson, Novartis, and Pfizer Inc. are vendors of record for providing smoking cessation pharmacotherapy, free or discounted, for research studies in which P.S. is the principal investigator or co-investigator. The other authors declare no conflict of interest.
This study was approved by the Research Ethics Board of the Centre for Addiction and Mental Health.
